시장보고서

상품코드

1462910

세계 치료용 핵의학 시장 : 유형별, 용도별, 최종 사용자별, 국가별, 지역별 산업 분석, 시장 규모, 시장 점유율, 예측(2024년-2032년)

Therapeutic Nuclear Medicine Market, By Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 04월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 303 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

치료용 핵의학 시장 규모는 2023년에 12억 3,200만 달러로 평가되었고 2024년부터 2032년에 걸쳐 복합 연간 성장률(CAGR) 4.5%로 확대될 전망입니다.

치료용 핵의학 시장 - 시장 역학

만성 질환 증가는 시장 수요를 촉진

암, 호흡기 질환, 신경 질환, 대사 질환, 심혈관 질환 등의 만성 질환의 유병률이 세계적으로 크게 증가하고 있습니다. 림프종 연구 재단에 따르면, 림프종은 미국 성인 및 소아에서 가장 빈번한 암이며 연간 100만 명 이상이 진단되고 있습니다. Global Burden of Diseases의 보고서에 따르면 심장병은 주요 사망 원인 중 하나이며 2018년 사망자 수는 약 1,800만 명입니다. 게다가 약 3,500만 명이 심장 관련 질환으로 고통받고 있으며, 이는 치료용 핵의학에 대한 수요를 끌어올리고 있습니다.

치료용 핵의학 시장 - 주요 인사이트

우리의 리서치 애널리스트가 공유한 분석에 따르면 시장은 예측 기간(2024년-2032년)에 약 4.5%의 복합 연간 성장률(CAGR)로 매년 성장할 것으로 예측됩니다.

유형별로 β방사체가 예측기간에 시장을 독점할 것으로 예측됩니다.

응용 분야별로 예측 기간 동안 종양학이 시장 성장을 이끌 것으로 예상됩니다.

최종 용도별로 병원은 예측 기간 동안 최대 시장 점유율을 차지할 것으로 예측됩니다.

지역별로는 북미가 2023년 매출을 선도

치료용 핵의학 시장 - 세분화 분석 :

세계 치료용 핵의학 시장은 유형, 용도, 최종 용도, 지역에 따라 세분화됩니다.

유형별로, 시장은 알파 방사체, 베타 방사체, 근접 조사 요법 아이소토프로 분류됩니다. β방사체 부문은 장거리 이동, 저에너지 수준, 이웃 세포에 대한 해가 적기 때문에 예측 기간 동안 시장을 독점할 것으로 예상됩니다.

용도별로 볼 때 시장은 심장병학, 뼈 스캔, 폐 스캔, 종양학, 신경학, 갑상선 적응, 골전이 등으로 나뉩니다. 종양학 분야는 세계 암의 유병률 상승으로 예측 기간 동안 시장 성장을 이끌 것으로 예상됩니다.

최종 용도에 따라 업계는 병원, 외래수술센터(ASC), 암 연구 기관으로 나뉩니다. 예측 기간 동안 병원이 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 이 부문의 성장은 암 유병률 증가와 병원 수 증가에 기인합니다.

치료용 핵의학 시장 - 지리적 인사이트

지역적으로, 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양 및 중동 및 아프리카 각 지역으로 퍼져 있습니다. 이 지역은 비즈니스를 전개하는 국가에 따라 더 나뉩니다. 북미는 예측 기간 동안 시장 점유율의 대부분을 차지할 것으로 예상됩니다. 이 지역 시장 확대는 암, 심혈관 등 만성 질환의 유병률 증가에 기인하고 있습니다. 예를 들어, 미국 암 협회의 추계에 따르면, 2022년에는 미국에서 새롭게 190만명의 암 환자가 진단되어, 60만9360명이 암으로 사망할 것으로 예측되고 있습니다. 이와 같이, 전술한 통계는 시장 성장의 원동력이 되고 있습니다.

치료용 핵의학 시장 - 경쟁 구도:

시장의 주요 기업은 Novartis AG, Bracco Imaging SpA, Bayer AG, Cardinal Health Inc., Mallinckrodt plc., Lantheus Medical Imaging Inc. GE Healthcare, Eckert &Ziegler, Curium Pharma, International Isotopes Idaho, Inc., Medi Co. 이들 기업은 제품 출시, 확대, 투자, 협업 등을 포함하여 시장의 최대 점유율을 얻기 위해 다양한 전략을 채택했습니다.

소개
북미
- 개요
- 북미 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제11장 주요 벤더 분석 - 치료용 핵의학 업계

경쟁 대시보드
기업 프로파일
- Novartis AG
- Bracco Imaging SpA
- Bayer AG
- Cardinal Health Inc.
- Mallinckrodt plc.
- Lantheus Medical Imaging Inc.
- GE Healthcare
- Eckert &Ziegler
- Curium Pharma
- International Isotopes Idaho, Inc.
- Medi-Radiopharma Co., Ltd.

제12장 애널리스트의 전방위 전망

BJH 24.05.23

REPORT HIGHLIGHT

Therapeutic Nuclear Medicine Market size was valued at USD 1,232 Million in 2023, expanding at a CAGR of 4.5% from 2024 to 2032.

The special properties of radioactive elements (radioisotopes) are utilized in therapeutic nuclear medicine (radionuclide treatment) to irradiate cells and/or organs. A radiopharmaceutical is usually injected or consumed in modest amounts to enter the body. Certain organs or tissues are drawn to the radiopharmaceutical. The radioisotopes release radiation, or tiny amounts of energy, from their positions within the body, which acts on target cells and/or organs. This radiation can be used as a palliative measure (e.g., for bone pain), a curative measure (e.g., thyroid cancer), or to decrease the function of an organ (e.g., overactive thyroid).

Therapeutic Nuclear Medicine Market- Market Dynamics

Increasing prevalence of chronic disease to propel market demand

There is a significant global increase in the prevalence of chronic diseases, including cancer, respiratory, neurological, and metabolic problems, as well as cardiovascular disease. According to the Lymphoma Research Foundation, lymphoma is the most frequent cancer among adults and children in the United States, accounting for over a million diagnoses annually. The Global Burden of Diseases reports that heart disease is one of the leading causes of death, accounting for approximately 18 million deaths in 2018. Additionally, approximately 35 million people suffer from heart-related conditions, which is driving up demand for therapeutic nuclear medicines.

Therapeutic Nuclear Medicine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.5% over the forecast period (2024-2032)

Based on type segmentation, the Beta Emitters segment is expected to dominate the market over the forecast period

Based on the application segmentation, the Oncology segment is expected to lead the market growth during the forecast period

Based on end user segmentation, the Hospitals segment is expected to hold the largest market share over the projected period

Based on region, North America was the leading revenue generator in 2023

Therapeutic Nuclear Medicine Market- Segmentation Analysis:

The Global Therapeutic Nuclear Medicine Market is segmented based on Type, Application, End User, and Region.

Based on the type, the market is categorized into Alpha Emitters, Beta Emitters and Brachytherapy Isotopes. The Beta Emitters segment is expected to dominate the market over the forecast period due to long distance travel, low energy levels, and less harm to nearby cells.

Based on the application, the market is divided into Cardiology, Bone Scans, Pulmonary Scans, Oncology, Neurology, Thyroid Indications, Bone Metastasis and Others. The Oncology segment is expected to lead the market growth during the forecast period due to the rise in the prevalence of cancer across the globe.

Based on the end user, the industry is divided into Hospitals, Ambulatory Surgical Centres and Cancer Research Institutes. The Hospitals segment is expected to hold the largest market share over the projected period. The segment growth is attributable to increase in the prevalence of cancer and increase in the number of hospitals.

Therapeutic Nuclear Medicine Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to hold the majority of market share during the forecast period. The regional market expansion is attributed to the growing prevalence of chronic disease such as cancer, cardiovascular and others. For instance, in 2022, there will be an anticipated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States, according to the American Cancer Society's estimates. Thus, the aforementioned stats drive the market growth.

Therapeutic Nuclear Medicine Market- Competitive Landscape:

The key players in the market are Novartis AG, Bracco Imaging S.p.A, Bayer AG, Cardinal Health Inc., Mallinckrodt plc., Lantheus Medical Imaging Inc., GE Healthcare, Eckert & Ziegler, Curium Pharma, International Isotopes Idaho, Inc. and Medi-Radiopharma Co., Ltd. These players adopted various strategies such as product launch, expansion, investment, collaboration, and others to obtain the maximum market share of the market.

Recent Developments:

In March 2022, Prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer (PSMA-positive mCRPC), which has spread to other parts of the body (metastatic), is a type of advanced cancer that Novartis announced the US Food and Drug Administration (FDA) had approved for treatment. PluvictoTM (lutetium Lu 177 vipivotide tetraxetan) was previously known as 177Lu-PSMA-617. Other anticancer treatments (inhibition of the androgen receptor pathway and taxane-based chemotherapy) have already been administered to these individuals.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL THERAPEUTIC NUCLEAR MEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Novartis AG

Bracco Imaging S.p.A

Bayer AG

Cardinal Health Inc.

Mallinckrodt plc.

Lantheus Medical Imaging Inc.

GE Healthcare

Eckert & Ziegler

Curium Pharma

International Isotopes Idaho, Inc.

Medi-Radiopharma Co., Ltd.

GLOBAL THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

Alpha Emitters
Beta Emitters
Brachytherapy Isotopes

GLOBAL THERAPEUTIC NUCLEAR MEDICINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Cardiology
Bone Scans
Pulmonary Scans
Oncology
Neurology
Thyroid Indications
Bone Metastasis
Others

GLOBAL THERAPEUTIC NUCLEAR MEDICINE MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

Hospitals
Ambulatory Surgical Centres
Cancer Research Institutes

GLOBAL THERAPEUTIC NUCLEAR MEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1.Therapeutic Nuclear Medicine Market Overview

1.1.Study Scope
1.2.Market Estimation Years

2.Executive Summary

2.1.Market Snippet
- 2.1.1.Therapeutic Nuclear Medicine Market Snippet by Type
- 2.1.2.Therapeutic Nuclear Medicine Market Snippet by Application
- 2.1.3.Therapeutic Nuclear Medicine Market Snippet by End User
- 2.1.4.Therapeutic Nuclear Medicine Market Snippet by Country
- 2.1.5.Therapeutic Nuclear Medicine Market Snippet by Region
2.2.Competitive Insights

3.Therapeutic Nuclear Medicine Key Market Trends

3.1.Therapeutic Nuclear Medicine Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
3.2.Therapeutic Nuclear Medicine Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
3.3.Therapeutic Nuclear Medicine Market Opportunities
3.4.Therapeutic Nuclear Medicine Market Future Trends

4.Therapeutic Nuclear Medicine Industry Study

4.1.PEST Analysis
4.2.Porter's Five Forces Analysis
4.3.Growth Prospect Mapping
4.4.Regulatory Framework Analysis

5.Therapeutic Nuclear Medicine Market: COVID-19 Impact Analysis

5.1.Pre-COVID-19 Impact Analysis
5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments

6.Therapeutic Nuclear Medicine Market Landscape

6.1.Therapeutic Nuclear Medicine Market Share Analysis, 2023
6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis

7.Therapeutic Nuclear Medicine Market - By Type

7.1.Overview
- 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
- 7.1.2.Alpha Emitters
- 7.1.3.Beta Emitters
- 7.1.4.Brachytherapy Isotopes

8.Therapeutic Nuclear Medicine Market - By Application

8.1.Overview
- 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
- 8.1.2.Cardiology
- 8.1.3.Bone Scans
- 8.1.4.Pulmonary Scans
- 8.1.5.Oncology
- 8.1.6.Neurology
- 8.1.7.Thyroid Indications
- 8.1.8.Bone Metastasis
- 8.1.9.Others

9.Therapeutic Nuclear Medicine Market - By End User

9.1.Overview
- 9.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
- 9.1.2.Hospitals
- 9.1.3.Ambulatory Surgical Centres
- 9.1.4.Cancer Research Institutes

10.Therapeutic Nuclear Medicine Market- By Geography

10.1.Introduction
- 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2.North America
- 10.2.1.Overview
- 10.2.2.Therapeutic Nuclear Medicine Key Manufacturers in North America
- 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.6.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.7.U.S.
  - 10.2.7.1.Overview
  - 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.7.5.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.8.Canada
  - 10.2.8.1.Overview
  - 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.8.5.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.Europe
- 10.3.1.Overview
- 10.3.2.Therapeutic Nuclear Medicine Key Manufacturers in Europe
- 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.6.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.7.Germany
  - 10.3.7.1.Overview
  - 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.7.5.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.8.Italy
  - 10.3.8.1.Overview
  - 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.8.5.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.9.United Kingdom
  - 10.3.9.1.Overview
  - 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.9.5.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.10.France
  - 10.3.10.1.Overview
  - 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.10.5.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.11.Russia
  - 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.11.4.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.12.Netherlands
  - 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.12.4.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.13.Sweden
  - 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.13.4.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.14.Poland
  - 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.14.4.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.15.Rest of Europe
  - 10.3.15.1.Overview
  - 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.15.5.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.Asia Pacific (APAC)
- 10.4.1.Overview
- 10.4.2.Therapeutic Nuclear Medicine Key Manufacturers in Asia Pacific
- 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.6.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.7.India
  - 10.4.7.1.Overview
  - 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.7.5.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.8.China
  - 10.4.8.1.Overview
  - 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.8.5.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.9.Japan
  - 10.4.9.1.Overview
  - 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.9.5.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.10.South Korea
  - 10.4.10.1.Overview
  - 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.10.5.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.11.Australia
  - 10.4.11.1.Overview
  - 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.11.5.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.12.Thailand
  - 10.4.12.1.Overview
  - 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.12.5.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.13.Indonesia
  - 10.4.13.1.Overview
  - 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.13.5.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.14.Philippines
  - 10.4.14.1.Overview
  - 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.14.5.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.15.Rest of APAC
  - 10.4.15.1.Overview
  - 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.15.5.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.Latin America
- 10.5.1.Overview
- 10.5.2.Therapeutic Nuclear Medicine Key Manufacturers in Latin America
- 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.6.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.7.Brazil
  - 10.5.7.1.Overview
  - 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.7.5.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.8.Mexico
  - 10.5.8.1.Overview
  - 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.8.5.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.9.Argentina
  - 10.5.9.1.Overview
  - 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.9.5.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.10.Colombia
  - 10.5.10.1.Overview
  - 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.10.5.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.11.Rest of LATAM
  - 10.5.11.1.Overview
  - 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.11.5.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.Middle East and Africa
- 10.6.1.Overview
- 10.6.2.Therapeutic Nuclear Medicine Key Manufacturers in Middle East and Africa
- 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.6.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.7.Saudi Arabia
  - 10.6.7.1.Overview
  - 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.7.5.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.8.United Arab Emirates
  - 10.6.8.1.Overview
  - 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.8.5.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.9.Israel
  - 10.6.9.1.Overview
  - 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.9.5.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.10.Turkey
  - 10.6.10.1.Overview
  - 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.10.5.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.11.Algeria
  - 10.6.11.1.Overview
  - 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.11.5.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.12.Egypt
  - 10.6.12.1.Overview
  - 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.12.5.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.13.Rest of MEA
  - 10.6.13.1.Overview
  - 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.13.5.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Therapeutic Nuclear Medicine Industry

11.1.Competitive Dashboard
11.2.Company Profiles
- 11.2.1.Novartis AG
- 11.2.2.Bracco Imaging S.p.A
- 11.2.3.Bayer AG
- 11.2.4.Cardinal Health Inc.
- 11.2.5.Mallinckrodt plc.
- 11.2.6.Lantheus Medical Imaging Inc.
- 11.2.7.GE Healthcare
- 11.2.8.Eckert & Ziegler
- 11.2.9.Curium Pharma
- 11.2.10.International Isotopes Idaho, Inc.
- 11.2.11.Medi-Radiopharma Co., Ltd.

12.360 Degree Analyst View

13.Appendix

13.1.Research End Userology
13.2.References
13.3.Abbreviations
13.4.Disclaimer
13.5.Contact Us